Antineoplastics/immunosuppressanntsFulminant hepatitis and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1891卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09296-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：44 / 44

相关论文

共 50 条

[1] Antineoplastics/folinic acidHyperammonaemia and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1983 (1) : 67 - 67
[2] Antineoplastics/voriconazoleCurvularia sinusitis and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1914 (1) : 79 - 79
[3] Antineoplastics/immunotherapiesDrug resistance and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1963 (1) : 84 - 84
[4] Antineoplastics/diazoxideOedema and lack of efficacy: 4 case reports
[J]. Reactions Weekly, 2023, 1940 (1) : 73 - 73
[5] Antineoplastics/aclarubicinMucosal adverse reaction and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1940 (1) : 72 - 72
[6] Antineoplastics/ribavirinCytopenia, hepatitis-E infection and lack of efficacy: 14 case reports
[J]. Reactions Weekly, 2023, 1966 (1) : 63 - 63
[7] Antineoplastics/lamivudineOccult hepatitis B infection reactivation and lack of efficacy: 19 case reports
[J]. Reactions Weekly, 2023, 1955 (1) : 55 - 55
[8] Antineoplastics/immune-globulinNeuritis and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1957 (1) : 55 - 55
[9] Antineoplastics/steroidsRash and lack of efficacy: 6 case reports
[J]. Reactions Weekly, 2022, 1935 (1) : 85 - 85
[10] Antineoplastics/entecavirHepatitis B reactivation and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1936 (1) : 77 - 77

← 1 2 3 4 5 →